Fit-for-purpose PK assay for a novel bispecific nanobody
Discover how Syngene developed a fit-for-purpose PK assay for a novel bispecific nanobody, achieving a 1.00 to 1000 ng/mL dynamic range and a low 1% repeat rate to support clinical dose selection.
Automation driven optimization of liver microsomal stability (LMS) assays for ADME studies
Syngene enhances ADME studies with automated liver microsomal stability assays, improving DMPK precision, boosting throughput, and accelerating ADME screening workflows.
Intraperitoneal Injection of Sesame Oil as Vehicle Induces Decidual Reaction in Female Rats: A Review of In-House Data
Publication: Sage Journal
The Future of Animal Health: How Integrated Small and Large Molecule Innovation Is Transforming Veterinary Therapeutics
Integrated cell line development and biologics development are reshaping veterinary therapeutics. Discover how multi-modality innovation drives impact—read more today.
Bile acid modulators in discovery: Identifying cholestasis candidates with the best chance of success
Publication: Pharmaceutical Technology Focus
India’s only GLP-certified viral testing and clearance services
Syngene has India’s only GLP-certified viral testing facility that offers comprehensive viral safety solutions for your biologics program. Whether it’s studies supporting applications for Phase I, Phase III, or marketing authorizations, we have consistently delivered them with responsibility and unwavering commitment. At Syngene, viral safety is non-negotiable. Delivering safe and high-quality drugs to patients is […]
The rise of ADCs in oncology: how antibody drug conjugate therapies deliver precision
Understand antibody drug conjugate science, bioconjugation, and manufacturing controls that shape targeted therapy for cancer. Read the article today.
Tech transfer in CDMOs: avoiding the scale-up trap
Tech transfer sounds like a handover, but in a CDMO, it is a stress test. A process that behaves in a bench hood can shift when it meets plant-scale mixing, utilities, sampling routines, and tighter execution windows.
How AI is Reshaping CRDMOs: Use Cases and Results from Discovery to Manufacturing
Process analytical technology in CRDMOs uses AI to improve quality, speed tech transfer, and scale mRNA manufacturing. Read the full article.
Self-amplifying RNA: the next chapter in mRNA therapeutics
Self-amplifying RNA (saRNA) is emerging as the next wave in mRNA-based therapeutics, building on the achievements of first-generation mRNA vaccines and treatments.